Acuta Capital Partners, LLC Arrowhead Pharmaceuticals, Inc. Transaction History

Acuta Capital Partners, LLC

$98.8 Million
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$25.16 - $41.38 $691,900 - $1.14 Million	27,500 New	27,500 $980,000
Q4 2022 Feb 14, 2023	SELL	$28.0 - $40.56 $1.3 Million - $1.88 Million	-46,471 Reduced 53.11%	41,029 $1.66 Million
Q3 2022 Nov 14, 2022	BUY	$29.63 - $48.31 $757,757 - $1.24 Million	25,574 Added 41.3%	87,500 $2.89 Million
Q2 2022 Aug 15, 2022	SELL	$27.79 - $50.61 $571,751 - $1.04 Million	-20,574 Reduced 24.94%	61,926 $2.18 Million
Q1 2022 May 16, 2022	SELL	$39.62 - $69.97 $911,259 - $1.61 Million	-23,000 Reduced 21.8%	82,500 $3.79 Million
Q4 2021 Feb 14, 2022	SELL	$58.09 - $82.51 $929,440 - $1.32 Million	-16,000 Reduced 13.17%	105,500 $7 Million
Q3 2021 Nov 15, 2021	BUY	$58.38 - $84.96 $788,130 - $1.15 Million	13,500 Added 12.5%	121,500 $7.59 Million
Q1 2021 May 17, 2021	SELL	$61.35 - $90.47 $1.9 Million - $2.8 Million	-31,000 Reduced 22.3%	108,000 $7.16 Million
Q4 2020 Feb 16, 2021	BUY	$43.82 - $85.37 $1.64 Million - $3.2 Million	37,500 Added 36.95%	139,000 $10.7 Million
Q3 2020 Nov 16, 2020	BUY	$33.21 - $51.27 $1.38 Million - $2.13 Million	41,500 Added 69.17%	101,500 $4.37 Million
Q2 2020 Aug 14, 2020	SELL	$26.12 - $43.27 $1.3 Million - $2.15 Million	-49,700 Reduced 45.31%	60,000 $2.59 Million
Q1 2020 May 15, 2020	SELL	$20.56 - $63.12 $6.84 Million - $21 Million	-332,800 Reduced 75.21%	109,700 $3.16 Million
Q4 2019 Feb 14, 2020	BUY	$28.14 - $73.01 $1.55 Million - $4.02 Million	55,000 Added 14.19%	442,500 $28.1 Million
Q3 2019 Nov 14, 2019	SELL	$26.26 - $34.86 $2.39 Million - $3.17 Million	-91,000 Reduced 19.02%	387,500 $10.9 Million
Q2 2019 Aug 14, 2019	BUY	$17.43 - $28.82 $5.42 Million - $8.96 Million	311,000 Added 185.67%	478,500 $12.7 Million
Q1 2019 May 14, 2019	BUY	$12.05 - $20.18 $2.02 Million - $3.38 Million	167,500 New	167,500 $3.07 Million
Q4 2018 Feb 14, 2019	SELL	$10.74 - $19.7 $8.32 Million - $15.3 Million	-775,000 Closed	0 $0
Q3 2018 Nov 07, 2018	SELL	$14.0 - $20.3 $3.57 Million - $5.18 Million	-255,330 Reduced 24.78%	775,000 $14.9 Million
Q2 2018 Aug 15, 2018	SELL	$6.37 - $14.02 $4.66 Million - $10.3 Million	-731,876 Reduced 41.53%	1,030,330 $14 Million
Q1 2018 May 15, 2018	BUY	$3.72 - $7.64 $6.56 Million - $13.5 Million	1,762,206 New	1,762,206 $12.7 Million

Others Institutions Holding ARWR

# of Institutions

295

Shares Held

91.1M

Call Options Held

155K

Put Options Held

426K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $1.96B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Acuta Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acuta Capital Partners, LLC with notifications on news.

Account